Literature DB >> 22378811

Telepharmacy in a rural Alberta Community Cancer Network.

Hollis L Gordon1, Michelle Hoeber, Adrienne Schneider.   

Abstract

Telepharmacy services were developed and adopted to compensate for the absence of a pharmacist in rural Cancer Centers. Preparation included the formation of an advisory committee, development of a training and certification process, establishing new policies and operating procedures, collecting utilization data and a survey of patient and user satisfaction. Pharmacy technicians at two remote community cancer centers were connected by telehealth with pharmacists at one of the two coordinating centers to oversee the compounding of intravenous (I.V.) chemotherapy and provide clinical review of physician orders. In 8 months of telepharmacy use, 247 intravenous preparations were compounded for 47 cancer patients during 109 treatment visits. Approximately 45,000 km (27,000 miles) of patient travel were averted. Pharmacy staff estimates requires an average of 10 additional minutes to process and compound each chemotherapy preparation. Nurses estimate an average of 27.5 additional minutes required to coordinate information for each patient order.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378811     DOI: 10.1177/1078155211431858

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  3 in total

Review 1.  The role of digital health technology in rural cancer care delivery: A systematic review.

Authors:  Bonny B Morris; Brianna Rossi; Bernard Fuemmeler
Journal:  J Rural Health       Date:  2021-09-04       Impact factor: 5.667

Review 2.  Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges.

Authors:  Arjun Poudel; Lisa M Nissen
Journal:  Integr Pharm Res Pract       Date:  2016-10-26

Review 3.  A Scoping Review of the Quality and the Design of Evaluations of Mobile Health, Telehealth, Smart Pump and Monitoring Technologies Performed in a Pharmacy-Related Setting.

Authors:  Darrin Baines; Imandeep K Gahir; Afthab Hussain; Amir J Khan; Philip Schneider; Syed S Hasan; Zaheer-Ud-Din Babar
Journal:  Front Pharmacol       Date:  2018-07-26       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.